Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4.

Alzheimers Res Ther

Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA.

Published: October 2010

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983440	PMC
http://dx.doi.org/10.1186/alzrt55	DOI Listing

Publication Analysis

prevention alzheimer's

alzheimer's disease

disease high

high risk

risk groups

groups statin

statin therapy

therapy subjects

subjects psen1

psen1 mutations

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!